Hepatitis B Surface Antigen without PCR reflex for REACTIVE

tabbed view

General Information

Lab Name
Hepatitis B surf Ag w/o RFLX
Lab Code
HBSAGX
Epic Ordering
Hepatitis B surf Ag w/o RFLX
Description

The Qualitative detection of Hepatitis B virus Surface Antigen (HBSAg) in human sera using the FDA approved ARCHITECT HBsAg test one-step chemiluminescent microparticle immunoassay (CMIA).

Part I:

Sample, assay diluent, and Hepatitis Surface antibody (anti-HBs) coated paramagnetic microparticles are combined. HBsAg present in the sample binds to the anti-HBs coated microparticles and to the anti-HBs acridinium-labeled conjugate. Then pre-trigger and trigger solutions are added to the reaction mixture. The resulting chemiluminescent reaction is measured as relative light units (RLUs).

The presence or absence of HBSAg in the sample is determined by comparing the chemiluminescent signal in the reaction to the cutoff signal determined from an ARCHITECT HBsAg calibration. Specimens with signal to cutoff (S/CO) values ≥ 1.00 are considered reactive for HBSAg. Specimens with S/CO values < 1.00 are considered nonreactive.

Reactive HBSAg are confirmed by neutralization assay at no charge (see part II).

Part II:

The Abbott ARCHITECT HBsAg Qualitative Confirmatory CMIA consists of two single tests, a neutralized and a non-neutralized or baseline assay, that are both one-step pre-treatment immunoassays:

Test 1 (neutralized)

Sample and Pre-Treatment reagent are combined in one reaction vessel (RV). When HBsAg is present in the sample, it is neutralized by the antibody (anti-HBs) in the Pre-Treatment Reagent.

Test 2 (non-neutralized)

Sample and diluent are combined in a second RV to serve as a baseline to calculate the % neutralization. Anti-HBs coated paramagnetic microparticles, and anti-HBs acridinium-labeled conjugate are added to each test RV. Any non-neutralized HBsAg present in the sample binds to the anti-HBs coated microparticles and to the anti-HBs acridinium-labeled conjugate. The neutralized HBsAg is blocked from forming a sandwich with acridinium-labeled anti-HBs conjugate and anti-HBs coated microparticles. Then pre-trigger and trigger solutions are added to the reaction mixtures. The resulting chemiluminescent reactions are measured as RLUs.

The presence or absence of HBSAg in the sample is determined by comparing the chemiluminescent signal in the reaction to the cutoff signal determined from an ARCHITECT HBsAg confirmatory calibration. Specimens with a ≥ 50% neutralization between the sample pretreated with Pre-Treatmeant reagent (test 1) and the sample pretreated with diluent (test 2) are confirmed positive for HBSAg.

For HBSAg testing with reflex testing, see Hepatitis B Surface Antigen (HBsAg) with reflex to PCR for REACTIVE [HBSAG]. Confirmed positives are reflexed to Hepatitis B Quantitative [HBVQNT] for final confirmation with an additional charge.

Synonyms
Components

Interpretation

Method

Chemiluminescence Immunoassay

Reference Range
See individual components
Guidelines

Ordering & Collection

Specimen Type
Blood
Collection

Blood: 5 mL blood in GOLD TOP serum separator tube (SST).

Also acceptable: 5 mL blood in ORANGE TOP rapid serum tube (RST) or RED TOP tube

Handling Instructions
Quantity
requested: 1.0 mL serum
minimum: 0.5 mL serum

Processing

Processing

Blood: Specimens may be stored on or off the clot, red blood cells, or separator gel for up to 3 days at room temperature (15-30°C) or up to 7 days at 2-8°C. If testing will be delayed more than 3 days for specimens stored at room temperature or more than 7 days for specimens stored at 2-8°C, remove serum from the clot, red blood cells, or separator gel and store at -20°C or colder. Avoid more than three freeze/thaw cycles.

Outside Laboratories: Specimens may be stored on or off the clot, red blood cells, or separator gel for up to 3 days at room temperature (15-30°C) or up to 7 days at 2-8°C. If testing will be delayed more than 3 days for specimens stored at room temperature or more than 7 days for specimens stored at 2-8°C, remove serum from the clot, red blood cells, or separator gel and store at -20°C or colder. Avoid more than three freeze/thaw cycles.

Unacceptable samples: Cord blood, neonatal specimens, cadaver specimens, heat-inactivated specimens, or body fluids such as saliva, urine, amniotic fluid, or pleural fluid. Specimens with obvious microbial contamination or are grossly hemolyzed.

Performance

LIS Dept Code
Clinical Virology (CVIR)
Performing Location(s)
Other Virology
206-685-8037

Virology Laboratory, Ste 320
1616 Eastlake Ave E.
Seattle, WA 98102

Frequency
Monday-Friday
Available STAT?
No

Billing & Coding

CPT codes
87340
LOINC
5196-1
Interfaced Order Code
UOW2239